About BICO
BICO is a publicly listed company based in Boston (United States) founded in 2016. Technologies, products, and services for life sciences research are provided. It operates in the Healthcare and Technology sectors. BICO has completed 4 acquisitions, including Advanced BioMatrix, Allegro 3D and Biosero. Its website bico.com draws about 11 thousand monthly visits. BICO offers products and services including Lab Automation Platform and Instruments. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and 3D Bioprinting. Its legal entity is BICO Group AB. Its competitors include CELLINK, Precise Bio and Allevi; 2 of its 3 listed competitors have raised funding.
Company details
BICO was founded in 2016 and is headquartered in Boston, United States. Operations focus on the life sciences sector, where technologies, products, and services are developed and marketed. Robotics, artificial intelligence, computer science, and 3D bioprinting are utilized to support cell culturing in 3D environments, high-throughput drug screening, and the printing of human tissues and organs. These capabilities serve the medical, pharmaceutical, and cosmetic industries.
- Annual Revenue$162.87 M (USD)-13.32as on Dec 31, 2025
- Net Profit-$118.35 M (USD)-20445.28as on Dec 31, 2025
- EBITDA-$1.93 M (USD)-121.95as on Dec 31, 2025
- Latest Funding Round$48.16M (USD), Post-IPO
Jan 2023
- InvestorsSartorius
& 1 more
- Investments & AcquisitionsAdvanced BioMatrix
& 3 more
Products & Services of BICO
BICO offers a comprehensive portfolio of products and services, including Lab Automation Platform and Instruments.
Platform for enabling end-to-end lab automation in life sciences.
Devices for lab processes and scientific research applications.
Funding Insights of BICO
- Total Rounds 2
- Last Round Post-IPO — $48.16M
- First Round $490,348
(Nov 2021)
- Investors Count 2
All 2 funding rounds of BICO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $48.16M | Post-IPO | – | – | |
| Nov 2021 | $490,348 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in BICO
BICO has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Sartorius and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BICO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BICO
23 people are tracked at BICO (13 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Martin K. | Head Of Global Manufacturing | Leadership |
Lars Ketilsson | Head Of Global Qa/ra | Leadership |
Maria Forss | President and CEO | Leadership |
Sebastian Mahl | Head Of Treasury | Leadership |
Jacob Thordenberg | Chief Financial Officer | Leadership |
Arash Mahmoudi | Head Of Corporate Development & Business Finance | Leadership |
Marius Balger | COO | Leadership |
Edmund Yap | Managing Director, Director Of Sales, Applications & Support Biosciences Asia Pacific | Leadership |
Itedale Namro | Chief Scientific Officer, Director Of Bioink And Tissue Engineering R&d | Leadership |
Marlene Gross | Head Of Global Supply Chain | Leadership |
Petros Apostolopoulos | Managing Director Business Unit Lab Instruments (cytena & Dispendix) | Leadership |
Andreas Glänfält | Head Of Global IT | Leadership |
Isabella Lundin | Head Of Executive Administration | Leadership |
Sarit Pal | Senior Scientist-field Applications | Team |
Alice Olsson | Group Financial Controller | Team |
Alan Dari Lindahl | Business Development & Control | Team |
Amna Wasim | QA Engineer | Team |
Kristofer Bodvard | Product Manager | Team |
Madeleine Savigny | Installation And Training Coordinator For Europe/middle East/africa Regions | Team |
Maya Ginsberg | Liquid Handling Sales Team Lead North America | Team |
3 more people are available in the full profile.
Complete people profiles for BICO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BICO
BICO is a publicly listed company on the OMXSTO with ticker symbol BICO in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Apr 2018
- Listed onNASDAQ OMX: BICO
- Listed entityBICO Group AB Class B
- Exchange sectorHealth technology
- ISINSE0013647385
- Share price25.10 SEK (+0.8% on the day) · 2026-10-14
- Market capitalisation1,757,314,853.00 SEK
- EPS (diluted, trailing year)-11.89 SEK
- Volume (last session)128,476
Financials of BICO
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.50B SEK | -1.09B SEK | -17.8M SEK |
| 2024 | 1.73B SEK | -5.3M SEK | 81.1M SEK |
| 2023 | 2.01B SEK | -1.17B SEK | 36.0M SEK |
| 2022 | 2.12B SEK | -789.8M SEK | -23.2M SEK |
| 2021 | 1.26B SEK | -193.9M SEK | -74.6M SEK |
Detailed financial statements for BICO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BICO
BICO has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Advanced BioMatrix, Allegro 3D and Biosero.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
3D bioprinting is used to develop human tissues and biomaterials. | allegro3d.com | San Diego, United States | 2017 | May 2022 | •••• | |
Software solutions are provided for automating laboratory workflows. | biosero.com | San Diego, United States | 2003 | Dec 2021 | $165M | |
Robotic instruments for sample preparation are developed by QInstruments. | qinstruments.com | Jena, Germany | 2003 | Oct 2021 | $70.98M | |
High quality collagen for cell culture, gels, coatings and other research applications and developer of bioinks for 3D printing | advancedbiomatrix.com | San Diego, United States | 2008 | Aug 2021 | •••• |
Complete acquisition details for BICO
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BICO
8 dated milestones of BICO across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BICO is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Advanced BioMatrix.
- Acquisition Acquires QInstruments.
- Funding First funding round of $490K.
- Acquisition Acquires Biosero.
- Acquisition Acquires Allegro 3D.
- Funding Latest funding round, Post-IPO, of $48.2M.
Competitors of BICO
BICO has 3 listed competitors in our database, 2 of them funded. They include CELLINK, Precise Bio and Allevi.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellink.com | 2016 | Boston, United States | 65 | 3D bioprinters and bioinks are developed for research applications. | ||
| precise-bio.com | 2015 | Winston-salem, United States | $12M | 6 | Developer of integrated 3D printing and tissue-engineering platform | |
| allevi3d.com | 2014 | Philadelphia, United States | $3.58M | Industrial-grade 3D bioprinters and bioprinting materials are manufactured. |
Detailed competitors of BICO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BICO
The website of BICO (bico.com) receives about 11.1K visits a month.
- Monthly visits11.1K
▲ 9.6% vs previous month
Websites whose visitors overlap most with BICO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aercap.com | 100% | 41.7K | #801,827 | View details | |
olsi.net | olsi.net | 63% | #1,024,556 | – | |
| temenos.com | 60% | 334K | #102,414 | View details | |
| discover-echo.com | 31% | 28.3K | #1,115,289 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as BICO (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bico
Complete news archive for BICO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BICO
BICO was founded in 2016 and raised its 1st funding round 5 years after it was founded.
BICO is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Annual revenue of BICO is $162.87M as on Dec 31, 2025.
BICO was founded in 2016 and is headquartered in Boston, United States. Operations focus on the life sciences sector, where technologies, products, and services are developed and marketed. Robotics, artificial intelligence, computer science, and 3D bioprinting are utilized to support cell culturing in 3D environments, high-throughput drug screening, and the printing of human tissues and organs. These capabilities serve the medical, pharmaceutical, and cosmetic industries.
BICO's top competitors include Allevi, CELLINK and Precise Bio.
BICO offers Lab Automation Platform and Instruments.
Yes, BICO is publicly traded on OMXSTO under the ticker symbol BICO.
BICO has made 4 acquisitions, including Advanced BioMatrix, Allegro 3D, and Biosero.
BICO has 2 investors. Key investors include Sartorius, and European Union.
BICO operates through Bico Group Ab.